share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  10/17 04:54

Moomoo AI 已提取核心訊息

Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on October 15, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely monitored by investors for insights into executive confidence in the company's performance.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on October 15, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely monitored by investors for insights into executive confidence in the company's performance.
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年10月15日執行了一筆非衍生證券交易。交易的具體細節,包括股票數量、交易價格和總價值,在公告中沒有披露。布爾拉作爲公司董事長兼首席執行官的關係使他處於具有重大影響力的位置,投資者密切監視這類交易,以獲取對公司業績的管理層 信懇智能 的見解。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年10月15日執行了一筆非衍生證券交易。交易的具體細節,包括股票數量、交易價格和總價值,在公告中沒有披露。布爾拉作爲公司董事長兼首席執行官的關係使他處於具有重大影響力的位置,投資者密切監視這類交易,以獲取對公司業績的管理層 信懇智能 的見解。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息